Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068677 · ClinicalTrials.gov registry record · NA
Evaluation of Injection Techniques in Celiac Plexus Neurolysis
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT02068677: Completed NA study, sponsored by AdventHealth.
NCT02068677 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02068677, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
1\. To evaluate the efficacy of EUS-CPN in subjects who experience a sympathetic response during injection when compared with subjects who do not experience sympathetic response during injection. EUS-CPN when performed in subjects who experience a sympathetic response during injection will have better pain relief when compared to subjects who do not experience a sympathetic response during injection.
Primary Outcome
The primary endpoint of the study is abdominal pain. It will be assessed with a standardized 11-point continuous visual analog pain scale with "0" equaling no pain, "5" moderate pain and "10" worst pain ever. Before the procedure, patient will be instructed in the use of the pain scale by the research nurse. After the procedure, pain scores will be assessed by the clinical research nurse at the predetermined intervals. A complete response will be defined as an absence of abdominal pain requirin
Interventions
- OTHER Sympathetic response
- OTHER no sympathetic response
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT02068677 record still lists
NCT02068677 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Sympathetic response is the first listed.
NCT02068677 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02068677 about?
NCT02068677 is a clinical study titled "Evaluation of Injection Techniques in Celiac Plexus Neurolysis". 1\. To evaluate the efficacy of EUS-CPN in subjects who experience a sympathetic response during injection when compared with subjects who do not experience sympathetic response during injection. EUS-CPN when performed in subjects who experience a sympathetic response during injection will have bet...
What is the current status of trial NCT02068677?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-08. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02068677?
The interventions under investigation include: Sympathetic response (OTHER), no sympathetic response (OTHER).
Who is sponsoring clinical trial NCT02068677?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02068677's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia